6 min read
July Fellow's Spotlight on Alicer Andrew
This month's Fellows Spotlight goes to Keystone Symposia Fellow Dr. Alicer Andrew! Born and raised on the Caribbean...
David Soto-Pantoja, PhD, investigates cell surface receptor CD47 as an immunotherapy for breast, lung, head and neck cancers and melanoma. Through clinical trials and animal model collaborations, he explores the effects of CD47 targeting on tumor cell bioenergetics, with the goal of developing anti-cancer therapeutics that inhibit tumor growth and prevent chemotherapy-related cardiac toxicity.
Research Area(s):
Research Keywords:
Mentor: Juanita L. Merchant, MD, PhD
Jul 17, 2025 by Keystone Symposia
This month's Fellows Spotlight goes to Keystone Symposia Fellow Dr. Alicer Andrew! Born and raised on the Caribbean...
May 6, 2025 by Shannon Weiman
Featuring...